首页> 外文OA文献 >POS0855 PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING

【2h】

POS0855 PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING

机译：POS0855患者偏好，权衡和可接受的风险，治疗系统性硬化症相关的间质性肺病：迈向共同决策的一步

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
C. Bruni; S. Heidenreich; A. Duenas; A. M. Hoffmann-Vold; A. Gabrielli; Y. Allanore; E. Chatelus; J. H. W. Distler; E. Hachulla; V. Hsu; N. Hunzelmann; D. Khanna; M. E. Truchetet; U. Walker; M. Alves; N. Schoof; L. A. Saketkoo; O. Distler;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide [J] . Numajiri Hiroko, Yoshizaki Ayumi, Ebata Satoshi, The Journal of dermatology . 2018,第6期

机译：在日本患者中使用Rituximab进行成功治疗，其具有抗身对口腔类固醇和环磷酰胺的全身硬化相关的间质性肺部疾病
2. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease [J] . Mendoza Fabian A., Piera-Velazquez Sonsoles, Farber John L., Arthritis & rheumatology. . 2016,第1期

机译：系统性硬化相关性间质性肺疾病患者肺组织中表达内皮和间充质细胞基因产物的内皮细胞
3. Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients [J] . Sari Alper, Guven Denizcan, Armagan Berkan, Journal of clinical rheumatology . 2017,第8期

机译：Rituximab患者在长期全身性硬化症相关间质肺病中的经验：一系列14名患者
4. Deep radiomic prediction with clinical predictors of the survival in patients with rheumatoid arthritis-associated interstitial lung diseases [C] . Radin A. Nasirudin, Janne J. Nappi, Chinatsu Watari, SPIE Medical Imaging Conference . 2018

机译：类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
5. Lung Cancer Screening: Identification of High-Risk Patients and Shared Decision-Making [D] . Formo, Teresa Dianna. 2020

机译：肺癌筛选：鉴定高危患者和共享决策
6. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease [O] . Eleanor Valenzi, Tracy Tabib, Anna Papazoglou, 2021

机译：不同干扰素信号和共同的异常无比基础细胞在特发性肺纤维化和全身硬化相关间质性肺病的单细胞分析中
7. POS0840 RISK OF MALNUTRITION IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): FURTHER ANALYSES OF THE SENSCIS TRIAL [O] . E. Volkmann, Z. Mcmahan, S. Johnson, 2021

机译：系统性硬化关联间质肺病（SSC-ILD）患者营养不良的营养不良风险：进一步分析了Senscis试验
8. Biomarker-Based Prediction Models for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease. [R] . Assassi, S. 2017

机译：基于生物标志物的系统性硬化相关间质性肺病治疗反应预测模型。

POS0855 PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING

著录项

引文网络

相似文献

相关主题

期刊订阅